Kunal Nepali

5PUBLICATIONS

11CO-AUTHORS

Haematological tumoursMolecular targetsCheminformatics and quantitative structure-activity relationships

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 09, 2026

Dual SYK-HDAC Inhibitor Elicits Striking Efficacy against Acute Myeloid Leukemia: Rational Design, Synthesis, and Biological Evaluation.

|Sep 25, 2024

Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids.

Po-Yu Chou, Mei-Jung Lai, Kelvin K Tsai

|Jan 29, 2024

First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo.

Sachin Sharma, Shao-An Wang, Wen-Bin Yang

|Jul 05, 2022

Glioblastoma: Current Status, Emerging Targets, and Recent Advances.

Amandeep Thakur, Chetna Faujdar, Ram Sharma

|Jun 16, 2018

Correction: 2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition.

Kunal Nepali, Sunil Kumar, Hsiang-Ling Huang

Pageof 1

Frequent Collaborators

Jing-Ping Liou

Ching-Chuan Kuo

Hsueh-Yun Lee

Shao-An Wang

Tsung-I Hsu

Po-Yu Chou

Kelvin K Tsai

Wen-Bin Yang

Ajmer Singh Grewal

Gurpreet Singh

Frequent Collaborators

Jing-Ping Liou

Ching-Chuan Kuo

Hsueh-Yun Lee

Shao-An Wang